Induction of a type 1 regulatory CD4 T cell response following Vβ8.2 DNA vaccination results in immune deviation and protection from experimental autoimmune encephalomyelitis

International Immunology

Volumn 13, Issue 6, 2001, Pages 835-841

  Kumar, Vipin ^b   Maglione, Jeannie ^a   Thatte, Jayant ^c   Pederson, Brian ^a   Sercarz, Eli ^a   Ward, E Sally ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

DNA vaccine; Experimental autoimmune encephalomyelitis; Regulatory T cells; Th1 Th2; TCR

Indexed keywords

CD4 ANTIGEN; DNA VACCINE; MYELIN BASIC PROTEIN; PLASMID DNA; T LYMPHOCYTE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG ACTIVITY; HUMORAL IMMUNITY; LYMPHOCYTE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; REGULATORY MECHANISM; T LYMPHOCYTE; TH2 CELL;

EID: 0034985055     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/13.6.835     Document Type: Article

References (39)

1. DNA vaccines
2. DNA vaccines: Immunology, application, and optimization
3. + T lymphocytes
4. + T cells against influenza virus induced by vaccination with nucleoprotein DNA
5. Cytotoxic T cell responses to DNA vaccination: Dependence on antigen presentation via class II MHC
6. h1)-specific vaccination
7. h1) immunity
8. Mechanism of action of CpG DNA
9. DNA vaccination: Transfection and activation of dendritic cells as key events for immunity
10. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope
11. + T cells after gene gun immunization
12. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
13. Autoimmune diseases of myelin
14. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy
15. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention
16. The T lymphocyte in experimental allergic encephalomyelitis
17. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells
18. h2 immunity
19. + T cells in recovery from antigen-induced autoimmune disease
20. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE)
21. Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis
22. TCR peptide-reactive T cells and peripheral tolerance to myelin basic protein
23. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
24. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein
25. Genetic vaccination: The advantages of going naked
26. + T cell dependent
27. + cells in T cell receptor peptide-induced clonal unresponsiveness
28. + T cells in murine experimental allergic encephalomyelitis
29. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis
30. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens
31. DNA immunization to prevent autoimmune diabetes
32. Epitope spreading
33. Determinant spreading during experimental autoimmune encephalomyelitis: Is it potentiating, protecting or participating in the disease?
34. Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR
35. Modulating the immune response to genetic immunization
36. Expression and secretion of T-cell receptor V alpha and V beta domains using Escherichia coli as a host
37. Rapid and efficient site-specific mutagenesis without phenotypic selection
38. Engineering hybrid genes without the use of restriction enzymes: Gene splicing by overlap extension
39. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells